CONTRALINE INC has a total of 19 patent applications. It increased the IP activity by 500.0%. Its first patent ever was published in 2017. It filed its patents most often in United States, WIPO (World Intellectual Property Organization) and Canada. Its main competitors in its focus markets medical technology, pharmaceuticals and computer technology are BIOPROTECT LTD, CHEN SHAOLIANG and AGARWAL GHANSHAM DAS.
# | Country | Total Patents | |
---|---|---|---|
#1 | United States | 8 | |
#2 | WIPO (World Intellectual Property Organization) | 4 | |
#3 | Canada | 2 | |
#4 | China | 2 | |
#5 | EPO (European Patent Office) | 2 | |
#6 | Australia | 1 |
# | Industry | |
---|---|---|
#1 | Medical technology | |
#2 | Pharmaceuticals | |
#3 | Computer technology | |
#4 | Machines |
# | Technology | |
---|---|---|
#1 | Implantable devices | |
#2 | Diagnosis and surgery | |
#3 | Object sterilising | |
#4 | Electrotherapy | |
#5 | Medical preparations | |
#6 | Therapeutic chemical compounds | |
#7 | Syringes | |
#8 | Healthcare informatics | |
#9 | Compounding processes | |
#10 | Image data processing |
# | Name | Total Patents |
---|---|---|
#1 | Eisenfrats Kevin | 16 |
#2 | Moran Eric | 11 |
#3 | Grover Greg | 10 |
#4 | Grover Gregory | 8 |
#5 | Eisenfrats Kevin S | 3 |
#6 | Kapadia Shrey | 1 |
#7 | Patel Suchi | 1 |
Publication | Filing date | Title |
---|---|---|
WO2021035217A1 | Compositions and methods for sustained drug release from an injectable hydrogel | |
US2020146876A1 | Systems and methods for delivering biomaterials | |
US2019038454A1 | Long-lasting and degradable implant compositions | |
CN111629684A | Methods and apparatus for delivering stimulation to an occluding implant | |
US2019053790A1 | Systems and methods for automated image recognition of implants and compositions with long-lasting echogenicity | |
EP3565484A1 | Methods for implanting and reversing stimuli-responsive implants | |
US2018028715A1 | Carbon-based compositions useful for occlusive medical devices and methods of making and using them |